Bridging the Synthetic and Biopolymer Worlds with Peptide-Drug Conjugates  by Weiss, Gregory A. & Chamberlin, Richard
Previews
201
6. Piacentini, M., and Colizzi, V. (1999). Immunol. Today 3, 130–134. 11. Schuppan, D., and Hahn, E.G. (2002). Science 297, 2218–2220.
12. Griffin, M., Casadio, R., and Bergamini, C.M. (2002). Biochem.7. Molberg, O., Mcadam, S.N., Korner, R., Quarsten, H., Kristi-
ansen, C., Madsen, L., Fugger, L., Scott, H., Noren, O., Roeps- J. 368, 377–396.
13. De Laurenzi, V., and Melino, G. (2001). Mol. Cell. Biol. 21,torff, P., et al. (1998). Nat. Med. 4, 713–717.
8. Koning, F., and Vader, W. (2003). Science 299, 513–515. 148–155.
14. Boyton, R.J., Lohmann, T., Londei, M., Kalbacher, H., Halder, T.,9. Shan, L., Molberg, O., Parrot, I., Hausch, F., Filiz, F., Gray, G.M.,
Sollid, L.M., and Khosla, C. (2002). Science 297, 2275–2279. Frater, A.J., Douek, D.C., Leslie, D.G., Flavell, R.A., and Altmann,
D.M. (1998). Int. Immunol. 10, 1765–1776.10. Hausch, F., Halttunen, T., Ma¨ki, M., and Khosla, C. (2003). Chem.
Biol., this issue, 225–231.
molecular diversity, but this perception will change as
a consequence of this innovative research producing
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Bridging the Synthetic
and Biopolymer Worlds libraries comprised of small molecule-peptide hybrids.
Though many methods for constructing peptide librar-with Peptide-Drug Conjugates
ies are available, the best physically connect each pep-
tide with its encoding DNA. Phage display is one exam-
ple of this methodology. Here, for each individual
Roberts and Li break the standard library mold by constituent of the library, the peptide is attached to the
generating hybrid libraries of small molecules tethered surface of a bacteriophage, a virus that infects bacteria,
to peptides. Hybrid libraries harness larger chemical and the DNA encoding the displayed peptide is encap-
and structural diversities and thus represent a new sulated by the phage particle (a convenient vehicle for
frontier in lead drug discovery. site-directed mutagenesis and sequencing to determine
the identity of the displayed peptide). Library diversity
At first glance, the report by Li and Roberts published is also vital for its value as a research tool. An underap-
in this issue of Chemistry & Biology would appear to be preciated source for generating diversity, whether DNA,
a move in the wrong direction [1]. Who would want to RNA, or peptide, is chemically synthesized degenerate
mess up a perfectly good small molecule by tethering oligonucleotides, made possible by phenomenally effi-
it to a peptide with the expected effective loss in phar- cient phosphoramidite coupling reactions. However,
macokinetics? The answer is affinity. The two research- when library diversities grow larger than about one mil-
ers have developed a clever way to boost drug affinities lion different peptides, assaying or screening each pep-
by tapping into the massive combinatorial potential of tide individually becomes impractical, and at this stage
peptide libraries. The technique holds promise for rap- strategies are required to select peptides with desirable
idly optimizing the binding affinities of lead molecules properties (e.g., binding to a particular receptor) before
without being confronted with the sometimes excruciat- amplifying the selectants. Another advantage of phage
ing task of preparing large libraries of small molecule display is that peptides selected for their desired proper-
analogs. ties can be readily amplified in an E. coli host. By re-
To accomplish their goal, Li and Roberts literally had peating the process of peptide selection and amplifica-
to bridge two important but distinct areas of drug lead tion multiple times, the staggering varieties of peptides
discovery: biopolymer libraries and small molecules. found in the original library can be narrowed down to a
Biopolymer libraries, which can offer dazzling molecular few peptides with sought-after characteristics.
diversities approaching a trillion or more different com- Li and Roberts use an alternative to phage display in
pounds, are central to this new technology. Libraries of this study. They utilized the mRNA display format that
biopolymers, such as peptides, RNA, or DNA, are readily traces its roots to studies of “polysomes” (multiple ribo-
accessible to researchers and are a standard tool used somes translating an mRNA transcript) carried out in
to generate ligands for a particular target or to screen the 1970s. This technology was improved in a number
for a lead compound or polypeptide drug with improved of ways in the 1990s, including the optimization of mRNA
affinity. The tremendous diversity of such libraries can 5 and 3 end sequences and the addition of chaperones
often provide a starting point for such screens with rela- to the in vitro translation mixture, to facilitate the synthe-
tively little synthetic effort [2]. On the other hand, combi- sis of peptide libraries with diversities greater than 1012
natorial libraries of small molecules are much more labo- different peptides [3, 4]. Perhaps the most significant
rious to prepare and rarely approach the levels of advance in the context of library synthesis was made
diversity possible with biopolymers. However, one cru- by Roberts and Szostak, who developed a technique to
cial advantage of using small molecules is the ability to covalently connect an mRNA to its peptide translation
explore the physical and chemical parameters of com- product [5]. To this end, the antibiotic puromycin and a
plementary molecular diversity well beyond the 20 natu- short DNA linker are first appended to the 3 end of
rally occurring amino acids or 5 nucleotides. Until now, synthetic mRNAs. When the ribosome translates this
combinatorial small molecule and biopolymer libraries modified mRNA, it stalls upon reaching the DNA linker,
and the puromycin at the tail of the mRNA/DNA hybridhave been considered separate approaches to generate
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enters the A site of the ribosome and forms an amide tained from a hybrid library of approximately a trillion
bond with the translated peptide. The result is a stable different peptide-drug conjugates. In addition to provid-
mRNA/DNA/peptide hybrid in which the translated pep- ing significant technological advances over the phage
tide is physically attached to the RNA from which it was display and standard mRNA display library protocols
translated and can, in turn, be amplified by PCR between described, the hybrid library has generated inhibitors to
rounds of peptide selection. PBP2a that could be useful for overcoming -lactam
Peptide-small molecule hybrid libraries could be con- resistance in methicillin-resistant S. aureus.
ceived in two ways. One possibility is that the hybrid The results presented by Li and Roberts may be most
library centers on a small lead molecule which is com- memorable for their promise of harnessing the vast di-
bined with a very large number of peptide appendages. versities of peptide/small molecules in a library format
The alternative is that a large peptide library is produced rather than for the specific achievement of tethering
containing combinations of the normal complement of penicillin to a peptide library. By appending the peptide
20 proteinogenic amino acids plus a noncoded residue/ to a site on penicillin known to tolerate (and benefit from)
small molecule. Roberts previously reported the prepa- additional functionality, the results of the experiment
ration of peptide libraries containing noncoded amino are perhaps not too surprising. The two researchers
acids (the equivalent of the small molecule in the present argue convincingly that the modest affinities achieved
report) that were prepared by suppression mutagenesis in their experiment are not indicative of the actual im-
[6]. This technique requires a substantial synthetic effort provement gained from the tethered peptide, and that
in the preparation of the requisite suppressor tRNA, and it is the 100-fold increase in affinity that demonstrates
furthermore, it is perhaps not generally recognized that the value of their technique. Regardless, this experiment
the efficiency of the suppression itself, i.e., introduction builds a bridge to a new frontier of peptide-small mole-
of the noncoded amino acid via “reading” of a stop cule hybrid libraries that holds far-reaching and exciting
codon signal by the synthetic acylated tRNA, is highly possibilities for rapidly optimizing small molecule bind-
variable. This element of capriciousness makes this ing affinities without the need to synthesize large librar-
route inefficient; thus, resorting to a more traditional ies of small molecules.
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Selecting Selective Suppressors
of Selective Uptake useful in therapy of atherosclerosis.
The selective uptake of HDL CE is a major pathway by
which plasma HDL cholesterol is delivered to the liverScavenger receptor BI (SR-BI) is a high-density lipo-
protein (HDL) receptor that mediates the selective up- and steroidogenic cells [1–3]. In contrast to the LDL
receptor pathway in which LDL particles are endocy-take of HDL cholesteryl ester (CE) and the bidirectional
flux of free cholesterol (FC). The identification of selec- tosed and degraded in cells to release cholesterol [4],
